Back D J, Breckenridge A M, Grimmer S F, Orme M L, Purba H S
Contraception. 1984 Sep;30(3):289-95. doi: 10.1016/0010-7824(84)90092-1.
The effects of a single dose of two antimalarial drugs chloroquine (CQ) and primaquine (PQ) on the pharmacokinetics of a combined oral contraceptive (O.C.) have been studied in volunteers. Each woman was studied on 3 separate occasions over 3 cycles and plasma concentrations of ethinyloestradiol (EE2) and levonorgestrel were measured by radioimmunoassay following administration of a single dose of O.C. (30 micrograms EE2 + 150 micrograms levonorgestrel) in the absence and presence of the antimalarial drugs (PQ, 45 mg; CQ, 300 mg). Neither CQ or PQ given 1 h before the O.C. had any significant effect on plasma concentrations of EE2 or levonorgestrel or on any pharmacokinetic parameter determined. There is therefore, no evidence that CQ or PQ interfere with the hepatic handling of O.C.'s. This is in contrast to previously reported inhibitory effects of PQ on the metabolism of antipyrine.
在志愿者中研究了单剂量的两种抗疟药物氯喹(CQ)和伯氨喹(PQ)对复方口服避孕药(O.C.)药代动力学的影响。每位女性在3个周期内分3次进行研究,在服用单剂量O.C.(30微克炔雌醇+150微克左炔诺孕酮)且不存在和存在抗疟药物(PQ 45毫克;CQ 300毫克)的情况下,通过放射免疫分析法测定血浆中炔雌醇(EE2)和左炔诺孕酮的浓度。在服用O.C.前1小时给予CQ或PQ,对EE2或左炔诺孕酮的血浆浓度或任何测定的药代动力学参数均无显著影响。因此,没有证据表明CQ或PQ会干扰O.C.在肝脏的代谢过程。这与之前报道的PQ对安替比林代谢的抑制作用形成对比。